Abstract
Eleven single-nucleotide polymorphisms (SNPs) spanning OPRD1 were examined in 1063 European Americans (EAs) (620 cases with substance dependence (SD), including 557 with alcohol dependence (AD), 225 with cocaine dependence (CD) and 111 with opioid dependence (OD), and 443 controls). Nominally significant associations (P<0.05) of five SNPs with SD were observed; only the association of the non-synonymous variant G80T with OD remained significant after correction for multiple testing using SNPSpD. Haplotype analyses with six tag SNPs indicated that a specific haplotype GCAACT, which harbors G80T G-allele and C921T C-allele, was significantly associated with AD (χ2=14.82, degrees of freedom (d.f.)=1, P<0.001), CD (χ2=9.19, d.f.=1, P=0.002) and OD (χ2=20.68, d.f.=1, P<0.001). Logistic regression analyses, with sex and age being considered, demonstrated that this haplotype had a risk effect on AD (P=0.03, β=1.86, odds ratio (OR)=6.43) and especially on OD (P<0.001, β=3.92, OR=50.57). Moreover, seven SNPs covering OPRK1 were examined in the majority of the above subjects (390 cases, including 327 AD, 177 CD and 97 OD subjects, and 358 controls). Although no significant differences in allele, genotype or haplotype frequency distributions were seen between cases and controls, a specific OPRK1 haplotype, GGCTTCT, was significantly associated with AD (χ2=8.12, d.f.=1, P=0.004). Logistic regression analyses also revealed its risk effect on AD (P=0.009, β=1.06, OR=2.90). Population stratification artifact was not observed in the sample. Taken together, our findings supported a positive association between OPRD1 variants and SD, and a positive haplotypic association between OPRK1 and AD in EAs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Prescott CA, Kendler KS . Genetic and environmental contributions to alcohol abuse and dependence in a population-based sample of male twins. Am J Psychiatry 1999; 156: 34–40.
Walters GD . The heritability of alcohol abuse and dependence: a meta-analysis of behavior genetic research. Am J Drug Alcohol Abuse 2002; 28: 557–584.
Tsuang MT, Lyons MJ, Eisen SA, Goldberg J, True W, Lin N et al. Genetic influences on DSM-III-R drug abuse and dependence: a study of 3,372 twin pairs. Am J Med Genet 1996; 67: 473–477.
Tsuang MT, Lyons MJ, Meyer JM, Doyle T, Eisen SA, Goldberg J et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Arch Gen Psychiatry 1998; 55: 967–972.
Matthes HW, Maldonado R, Simonin F, Valverde O, Slowe S, Kitchen I et al. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature 1996; 383: 819–823.
Di CG, North RA . Neurobiology of opiate abuse. Trends Pharmacol Sci 1992; 13: 185–193.
Heyman JS, Vaught JL, Raffa RB, Porreca F . Can supraspinal delta-opioid receptors mediate antinociception? Trends Pharmacol Sci 1988; 9: 134–138.
Herz A . Endogenous opioid systems and alcohol addiction. Psychopharmacology Berl 1997; 129: 99–111.
Zhu Y, King MA, Schuller AG, Nitsche JF, Reidl M, Elde RP et al. Retention of supraspinal delta-like analgesia and loss of morphine tolerance in delta opioid receptor knockout mice. Neuron 1999; 24: 243–252.
Cowan A, Zhu XZ, Mosberg HI, Omnaas JR, Porreca F . Direct dependence studies in rats with agents selective for different types of opioid receptor. J Pharmacol Exp Ther 1988; 246: 950–955.
Maldonado R, Negus S, Koob GF . Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists. Neuropharmacology 1992; 31: 1231–1241.
Traynor JR, Elliott J . delta-Opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol Sci 1993; 14: 84–86.
Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F et al. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 2000; 25: 195–200.
Suzuki T, Narita M, Takahashi Y, Misawa M, Nagase H . Effects of nor-binaltorphimine on the development of analgesic tolerance to and physical dependence on morphine. Eur J Pharmacol 1992; 213: 91–97.
Narita M, Takahashi Y, Takamori K, Funada M, Suzuki T, Misawa M et al. Effects of kappa-agonist on the antinociception and locomotor enhancing action induced by morphine in mice. Jpn J Pharmacol 1993; 62: 15–24.
Pfeiffer A, Brantl V, Herz A, Emrich HM . Psychotomimesis mediated by kappa opiate receptors. Science 1986; 233: 774–776.
Turchan J, Przewlocka B, Toth G, Lason W, Borsodi A, Przewlocki R . The effect of repeated administration of morphine, cocaine and ethanol on mu and delta opioid receptor density in the nucleus accumbens and striatum of the rat. Neuroscience 1999; 91: 971–977.
Kim JA, Pollak KA, Hjelmstad GO, Fields HL . A single cocaine exposure enhances both opioid reward and aversion through a ventral tegmental area-dependent mechanism. Proc Natl Acad Sci USA 2004; 101: 5664–5669.
Mitchell JM, Liang MT, Fields HL . A single injection of the kappa opioid antagonist norbinaltorphimine increases ethanol consumption in rats. Psychopharmacology Berl 2005; 182: 384–392.
Froehlich JC, Zweifel M, Harts J, Lumeng L, Li TK . Importance of delta opioid receptors in maintaining high alcohol drinking. Psychopharmacology Berl 1991; 103: 467–472.
Di CG, Acquas E, Tanda G . Ethanol as a neurochemical surrogate of conventional reinforcers: the dopamine-opioid link. Alcohol 1996; 13: 13–17.
Ciccocioppo R, Martin-Fardon R, Weiss F . Effect of selective blockade of mu1 or delta opioid receptors on reinstatement of alcohol-seeking behavior by drug-associated stimuli in rats. Neuropsychopharmacology 2002; 27: 391–399.
O’Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B . Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry 1992; 49: 881–887.
Volpicelli JR, Alterman AI, Hayashida M, O’brien CP . Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 1992; 49: 876–880.
Heidbreder C, Goldberg SR, Shippenberg TS . Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. Eur J Pharmacol 1993; 243: 123–127.
Shippenberg TS, Heidbreder C . The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol 1995; 280: 55–61.
Bond C, LaForge KS, Tian M, Melia D, Zhang S, Borg L et al. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction. Proc Natl Acad Sci USA 1998; 95: 9608–9613.
Szeto CY, Tang NL, Lee DT, Stadlin A . Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts. Neuroreport 2001; 12: 1103–1106.
Tan EC, Tan CH, Karupathivan U, Yap EP . Mu opioid receptor gene polymorphisms and heroin dependence in Asian populations. Neuroreport 2003; 14: 569–572.
Bart G, Heilig M, LaForge KS, Pollak L, Leal SM, Ott J et al. Substantial attributable risk related to a functional mu-opioid receptor gene polymorphism in association with heroin addiction in central Sweden. Mol Psychiatry 2004; 9: 547–549.
Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E et al. A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry 2002; 7: 224–228.
Town T, Abdullah L, Crawford F, Schinka J, Ordorica PI, Francis E et al. Association of a functional mu-opioid receptor allele +118A with alcohol dependency. Am J Med Genet 1999; 88: 458–461.
Kim SG, Kim CM, Kang DH, Kim YJ, Byun WT, Kim SY et al. Association of functional opioid receptor genotypes with alcohol dependence in Koreans. Alcohol Clin Exp Res 2004; 28: 986–990.
Bart G, Kreek MJ, Ott J, LaForge KS, Proudnikov D, Pollak L et al. Increased attributable risk related to a functional mu-opioid receptor gene polymorphism in association with alcohol dependence in central Sweden. Neuropsychopharmacology 2005; 30: 417–422.
Hoehe MR, Kopke K, Wendel B, Rohde K, Flachmeier C, Kidd KK et al. Sequence variability and candidate gene analysis in complex disease: association of mu opioid receptor gene variation with substance dependence. Hum Mol Genet 2000; 9: 2895–2908.
Luo X, Kranzler HR, Zhao H, Gelernter J . Haplotypes at the OPRM1 locus are associated with susceptibility to substance dependence in European-Americans. Am J Med Genet B Neuropsychiatr Genet 2003; 120: 97–108.
Zhang H, Luo X, Kranzler HR, Lappalainen J, Yang BZ, Krupitsky E et al. Association between two {micro}-opioid receptor gene OPRM1 haplotype blocks and drug or alcohol dependence. Hum Mol Genet 2006; 15: 807–819.
Arias A, Feinn R, Kranzler HR . Association of an Asn40Asp A118G polymorphism in the mu-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 2006; 83: 262–268.
Uhl GR, Childers S, Pasternak G . An opiate-receptor gene family reunion. Trends Neurosci 1994; 17: 89–93.
Mayer P, Rochlitz H, Rauch E, Rommelspacher H, Hasse HE, Schmidt S et al. Association between a delta opioid receptor gene polymorphism and heroin dependence in man. Neuroreport 1997; 8: 2547–2550.
Gelernter J, Kranzler HR . Variant detection at the delta opioid receptor OPRD1 locus and population genetics of a novel variant affecting protein sequence. Hum Genet 2000; 107: 86–88.
Franke P, Nothen MM, Wang T, Neidt H, Knapp M, Lichtermann D et al. Human delta-opioid receptor gene and susceptibility to heroin and alcohol dependence. Am J Med Genet 1999; 88: 462–464.
Xu K, Liu XH, Nagarajan S, Gu XY, Goldman D . Relationship of the delta-opioid receptor gene to heroin abuse in a large Chinese case/control sample. Am J Med Genet 2002; 110: 45–50.
Loh eW, Fann CS, Chang YT, Chang CJ, Cheng AT . Endogenous opioid receptor genes and alcohol dependence among Taiwanese Han. Alcohol Clin Exp Res 2004; 28: 15–19.
Vadasz C, Saito M, Gyetvai B, Mikics E, Vadasz C . Scanning of five chromosomes for alcohol consumption loci. Alcohol 2000; 22: 25–34.
Yuferov V, Fussell D, LaForge KS, Nielsen DA, Gordon D, Ho A et al. Redefinition of the human kappa opioid receptor gene OPRK1 structure and association of haplotypes with opiate addiction. Pharmacogenetics 2004; 14: 793–804.
Gelernter J, Panhuysen C, Weiss R, Brady K, Hesselbrock V, Rounsaville B et al. Genomewide linkage scan for cocaine dependence and related traits: significant linkages for a cocaine-related trait and cocaine-induced paranoia. Am J Med Genet B Neuropsychiatr Genet 2005; 136: 45–52.
Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L et al. Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 2006; 11: 1016–1024.
Shi MM, Myrand SP, Bleavins MR, de la Iglesia FA . High throughput genotyping for the detection of a single nucleotide polymorphism in NADPH quinone oxidoreductase DT diaphorase using TaqMan probes. Mol Pathol 1999; 52: 295–299.
Stein MB, Schork NJ, Gelernter J . A polymorphism of the beta1-adrenergic receptor is associated with low extraversion. Biol Psychiatry 2004; 56: 217–224.
Yang BZ, Zhao H, Kranzler HR, Gelernter J . Practical population group assignment with selected informative markers: characteristics and properties of Bayesian clustering via STRUCTURE. Genet Epidemiol 2005; 28: 302–312.
Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet 1998; 63: 1839–1851.
Pritchard JK, Rosenberg NA . Use of unlinked genetic markers to detect population stratification in association studies. Am J Hum Genet 1999; 65: 220–228.
Falush D, Stephens M, Pritchard JK . Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies. Genetics 2003; 164: 1567–1587.
Luo X, Kranzler HR, Zuo L, Yang BZ, Lappalainen J, Gelernter J . ADH4 gene variation is associated with alcohol and drug dependence: results from family controlled and population-structured association studies. Pharmacogenet Genomics 2005; 15: 755–768.
Pritchard JK, Stephens M, Donnelly P . Inference of population structure using multilocus genotype data. Genetics 2000; 155: 945–959.
Barrett JC, Fry B, Maller J, Daly MJ . Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005; 21: 263–265.
Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al. The structure of haplotype blocks in the human genome. Science 2002; 296: 2225–2229.
Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, Calafell F et al. Population genetics of a functional variant of the dopamine beta-hydroxylase gene DBH. Am J Med Genet 1997; 74: 374–379.
Wittke-Thompson JK, Pluzhnikov A, Cox NJ . Rational inferences about departures from Hardy-Weinberg equilibrium. Am J Hum Genet 2005; 76: 967–986.
Liu K, Muse SV . PowerMarker: an integrated analysis environment for genetic marker analysis. Bioinformatics 2005; 21: 2128–2129.
Nyholt DR . A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 2004; 74: 765–769.
Terry CF, Loukaci V, Green FR . Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000; 275: 18138–18144.
Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MJ, Ehm MG . Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 2002; 53: 79–91.
Luo X, Kranzler HR, Zuo L, Wang S, Blumberg HP, Gelernter J . CHRM2 gene predisposes to alcohol dependence, drug dependence and affective disorders: results from an extended case-control structured association study. Hum Mol Genet 2005; 14: 2421–2434.
Jordan BA, Cvejic S, Devi LA . Opioids and their complicated receptor complexes. Neuropsychopharmacology 2000; 23: S5–S18.
Ananthan S . Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics. AAPS J 2006; 8: E118–E125.
The International HapMap Consortium. The International HapMap Project. Nature 2003; 426: 789–796.
Bray NJ, Buckland PR, Owen MJ, O’Donovan MC . Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 2003; 113: 149–153.
Pastinen T, Hudson TJ . Cis-acting regulatory variation in the human genome. Science 2004; 306: 647–650.
Acknowledgements
We appreciate excellent technical assistance from Ann Marie Lacobelle, Greg Kay and Yakov D Lozovatsky. This work was supported in part by funds from the National Institute on Drug Abuse (R01DA12849, R01DA12690 and K24DA15105), the National Institute on Alcohol Abuse and Alcoholism (R01AA11330, P50AA12870, K08AA13732 and K24AA13736) and the National Center for Research Resources (M01RR06192; University of Connecticut General Clinical Research Center); and the US Department of Veterans Affairs (the National Center for PTSD Research, the VA Medical Research Program and the VA Connecticut-Massachusetts Mental Illness Research, Education and Clinical Center (MIRECC), and VA Research Enhancement Award Program (REAP), and MERIT program).
Author information
Authors and Affiliations
Corresponding author
Additional information
Supplementary Information accompanies the paper on the Molecular Psychiatry website (http://www.nature.com/mp)
Rights and permissions
About this article
Cite this article
Zhang, H., Kranzler, H., Yang, BZ. et al. The OPRD1 and OPRK1 loci in alcohol or drug dependence: OPRD1 variation modulates substance dependence risk. Mol Psychiatry 13, 531–543 (2008). https://doi.org/10.1038/sj.mp.4002035
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4002035
Keywords
This article is cited by
-
Novel digital approaches to the assessment of problematic opioid use
BioData Mining (2022)
-
Association of OPRM1 with addiction: a review on drug, alcohol and smoking addiction in worldwide population
Egyptian Journal of Medical Human Genetics (2022)
-
Genetic susceptibility of opioid receptor genes polymorphism to drug addiction: A candidate-gene association study
BMC Psychiatry (2021)
-
A review of the existing literature on buprenorphine pharmacogenomics
The Pharmacogenomics Journal (2021)
-
Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence
Journal of Human Genetics (2020)